Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Tempus

Biotech & Life Sciences · Chicago, United States · Founded 2015 · IPO 2024 Decacorn

A technology company advancing precision medicine through the practical application of artificial intelligence in healthcare

Valuation
$11B
Market cap · May/2026
Revenue
$1.27B
Latest reported FY

Investors

9 investors on Tempus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Lightbank
Series B+ 8 investors entered at this stage

Global footprint

Where Tempus has talent and traffic

AI talent share
3.5% of workforce is AI talent
(104 of 3,010 staff)
Core AI391.3%
Other AI652.16%
Non-AI workforce2,90696.54%
Workforce by country
23 countries with
team presence
🇺🇸 United States97.6%
🇨🇦 Canada0.7%
🇪🇸 Spain0.5%
🇬🇧 United Kingdom0.2%
🇫🇷 France0.1%
Top 5 of 23 shown
Web traffic by country
140K monthly visits
across markets
🇺🇸 United States44.4%
🇨🇦 Canada6.9%
🏳️ Korea4.7%
🏳️ Republic of3.7%
🇮🇳 India2.7%
Top 5 markets shown

Patent intelligence

$32M patent portfolio · 111 active families

Estimated portfolio value
$32M
0.30% of market cap · 4.2× the top peer Sophia Genetics ($8M)
111 active patent families
Where Tempus innovates BioinformaticsMedicineData miningMolecular biologyComputational biology

Where Tempus concentrates vs peers

Each axis is a top-10 topic across Tempus and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Tempus's 4 investments and acquisitions.

Every disclosed deal where Tempus appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Tempus's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Tempus deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Tempus's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Tempus

        An AI-synthesized read of the highest-engagement posts about Tempus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Tempus on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.